Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Clinirx Research Private Limited, is an unlisted private company incorporated on 07 May, 2004. It is classified as a private limited company and is located in Kolkata, West Bengal. It's authorized share capital is INR 20.05 cr and the total paid-up capital is INR 10.85 cr.
Clinirx Research's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by 49.13% over the previous year. At the same time, it's book networth has increased by 10.17%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Pawan Kumar Rustagi | 00006979 | 13 years |
| Director | Sujit Kumar Mukherjee | 00271301 | 22 years |
| Director | Shiv Kumar Issar | 08455324 | 7 years |
| Kmp | . Nayantika | <HIDDEN> | 2 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| TERRESTRIAL FINANCE LTD. |
Not available for efiling
|
17.5 Cr | 1 | West Bengal |
| NETFLIER FINCO LIMITED |
Amalgamated
|
10.3 Cr | 1 | Delhi |
| TERRESTRIAL FINANCE LIMITED |
Amalgamated
|
17.5 Cr | 1 | Delhi |
| BMF INVESTMENTS LIMITED |
Active
|
30.2 L | 1 | Delhi |
| SOUTHERN SPINNERS AND PROCESSORS LIMITED |
Active
|
5.0 Cr | 1 | Tamil Nadu |
| JK PLANT BIO SCIENCES RESEARCH LIMITED |
Active
|
5.0 L | 1 | West Bengal |
| BHUVAS ELEMENTS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Delhi |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| CliniRx Asia Pacific Ltd. | Hong Kong | - | - |
| CliniRX USA Inc. | United States | - | - |
| CliniRx UK Ltd. | United Kingdom | - | - |
Read more
The incorporation date of CLINIRX RESEARCH PRIVATE LIMITED is 07 May, 2004
The authorized share capital of CLINIRX RESEARCH PRIVATE LIMITED is INR ₹ 20.1 Cr.
The paid-up capital of CLINIRX RESEARCH PRIVATE LIMITED is INR ₹ 10.8 Cr.
The registered address of CLINIRX RESEARCH PRIVATE LIMITED is 7 COUNCIL HOUSE STREET KOLKATA West Bengal - 700001
The CIN number of CLINIRX RESEARCH PRIVATE LIMITED is U85110WB2004PTC098498.